Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha-Synuclein | 6 | 2025 | 130 | 2.800 |
Why?
|
| Parkinson Disease | 6 | 2025 | 671 | 1.660 |
Why?
|
| Brain | 6 | 2024 | 1649 | 1.300 |
Why?
|
| Lewy Body Disease | 2 | 2025 | 97 | 0.920 |
Why?
|
| Multiple System Atrophy | 1 | 2025 | 32 | 0.910 |
Why?
|
| Proteomics | 1 | 2025 | 88 | 0.890 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 444 | 0.870 |
Why?
|
| Lewy Bodies | 2 | 2022 | 193 | 0.820 |
Why?
|
| Neurons | 3 | 2022 | 340 | 0.810 |
Why?
|
| Appendix | 2 | 2021 | 4 | 0.790 |
Why?
|
| Protein Aggregates | 4 | 2024 | 9 | 0.580 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 27 | 0.510 |
Why?
|
| Animals | 7 | 2024 | 3647 | 0.470 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 225 | 0.360 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 84 | 0.340 |
Why?
|
| Mice | 3 | 2024 | 1426 | 0.310 |
Why?
|
| Male | 6 | 2025 | 14878 | 0.270 |
Why?
|
| Disease Progression | 2 | 2019 | 672 | 0.260 |
Why?
|
| Humans | 7 | 2025 | 27263 | 0.240 |
Why?
|
| Aged | 3 | 2025 | 9120 | 0.230 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2024 | 3 | 0.220 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2024 | 5 | 0.220 |
Why?
|
| Alkaline Phosphatase | 1 | 2024 | 19 | 0.220 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 4841 | 0.220 |
Why?
|
| Phosphorylation | 1 | 2024 | 147 | 0.220 |
Why?
|
| beta-Globins | 1 | 2022 | 3 | 0.190 |
Why?
|
| Lysosomes | 1 | 2021 | 26 | 0.180 |
Why?
|
| Autophagy | 1 | 2021 | 35 | 0.180 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 374 | 0.180 |
Why?
|
| Neuroprotection | 1 | 2020 | 5 | 0.170 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 35 | 0.170 |
Why?
|
| Biopolymers | 1 | 2019 | 6 | 0.160 |
Why?
|
| Interneurons | 1 | 2019 | 5 | 0.160 |
Why?
|
| Female | 4 | 2025 | 15332 | 0.160 |
Why?
|
| Prions | 1 | 2019 | 7 | 0.160 |
Why?
|
| Protein Transport | 1 | 2019 | 33 | 0.160 |
Why?
|
| Gene-Environment Interaction | 1 | 2019 | 18 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2019 | 43 | 0.160 |
Why?
|
| Models, Neurological | 1 | 2019 | 27 | 0.160 |
Why?
|
| Amyloid | 1 | 2019 | 57 | 0.160 |
Why?
|
| Prefrontal Cortex | 1 | 2020 | 136 | 0.160 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 183 | 0.150 |
Why?
|
| Middle Aged | 2 | 2025 | 9068 | 0.150 |
Why?
|
| Sweden | 1 | 2018 | 9 | 0.150 |
Why?
|
| Mutant Proteins | 1 | 2018 | 7 | 0.150 |
Why?
|
| Appendectomy | 1 | 2018 | 14 | 0.150 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 272 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 275 | 0.150 |
Why?
|
| Age of Onset | 1 | 2018 | 95 | 0.150 |
Why?
|
| Rats | 2 | 2017 | 659 | 0.140 |
Why?
|
| Succinimides | 1 | 2017 | 1 | 0.140 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2017 | 9 | 0.140 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 6 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2016 | 18 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 328 | 0.120 |
Why?
|
| Risk Factors | 1 | 2018 | 2335 | 0.100 |
Why?
|
| DNA Methylation | 2 | 2021 | 164 | 0.080 |
Why?
|
| Dioxygenases | 1 | 2020 | 1 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 20 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 265 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2020 | 310 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 13 | 0.030 |
Why?
|